IR@PKUHSC  > 北京大学药学院  > 药剂学系
学科主题药学
A potential target associated with both cancer and cancer stem cells: A combination therapy for eradication of breast cancer using vinorelbine stealthy liposomes plus parthenolide stealthy liposomes
Liu, Yang; Lu, Wan-Liang; Guo, Jia; Du, Ju; Li, Ting; Wu, Jin-Wei; Wang, Gui-Ling; Wang, Jian-Cheng; Zhang, Xuan; Zhang, Qiang
关键词cancer stem cells breast cancer vinorelbine stealthy liposomes parthenolide stealthy liposomes side population
刊名JOURNAL OF CONTROLLED RELEASE
2008-07-02
DOI10.1016/j.jconrel.2008.03.022
129期:1页:18-25
收录类别SCI
文章类型Article
WOS标题词Science & Technology
类目[WOS]Chemistry, Multidisciplinary ; Pharmacology & Pharmacy
研究领域[WOS]Chemistry ; Pharmacology & Pharmacy
关键词[WOS]MYELOGENOUS LEUKEMIA STEM ; SIDE-POPULATION ; PROGENITOR CELLS ; LUNG-CANCER ; IN-VIVO ; CHEMOTHERAPY ; IDENTIFICATION ; CARCINOMA ; EFFICACY ; LINE
英文摘要

The cancer stem cells play a critical role in both initiation and relapse of the cancers as they are resistant to the most of cytotoxic agents and able to proliferate indefinitely. Vinorelbine stealthy liposomes and parthenolide stealthy liposomes were developed for providing beneficial pharmacological properties and to eradicate cancer stem cells and non-stem cancer cells together by a combination therapy. Cytotoxicity and cancer stem-like cells (side population, SP) identification were performed on human breast cancer cell lines MCF-7 and MDA-MB-231. SP cells were further sorted from MCF-7 cells and characterized. Inhibitory effect was evaluated on the sorted SP and non-SP cells. Antitumor activity was evaluated on MCF-7 xenografts in nude mice. SP cells were identified with a higher percentage in MCF-7 cells (3.8%) and lower in MDA-MB-231 cells (0.6%). Both vinorelbine and parthenolide inhibited the proliferation in MCF-7 and MDA-MB-231 cells. As compared to non-SP cells, inhibitory effect of vinorelbine in the SP cells was lower while a robust inhibitory effect was observed when applying vinorelbine in combination with parthenolide. In the MCF-7 xenografts, stealthy liposomal vinorelbine plus stealthy liposomal parthenolide produced a full inhibitory effect. This combination therapy may provide a potential strategy for eradication of breast cancer by targeting cancer together with cancer stem cells. (c) 2008 Elsevier B.V. All rights reserved.

语种英语
WOS记录号WOS:000257721100003
引用统计
被引频次:80[WOS]   [WOS记录]     [WOS相关记录]
文献类型期刊论文
条目标识符http://ir.bjmu.edu.cn/handle/400002259/66526
专题北京大学药学院_药剂学系
作者单位1.Peking Univ, Sch Pharmaceut Sci, Dept Pharmaceut, Beijing 100083, Peoples R China
2.Peking Univ, State Key Lab Nat & Biomimet Drugs, Beijing 100083, Peoples R China
推荐引用方式
GB/T 7714
Liu, Yang,Lu, Wan-Liang,Guo, Jia,et al. A potential target associated with both cancer and cancer stem cells: A combination therapy for eradication of breast cancer using vinorelbine stealthy liposomes plus parthenolide stealthy liposomes[J]. JOURNAL OF CONTROLLED RELEASE,2008,129(1):18-25.
APA Liu, Yang.,Lu, Wan-Liang.,Guo, Jia.,Du, Ju.,Li, Ting.,...&Zhang, Qiang.(2008).A potential target associated with both cancer and cancer stem cells: A combination therapy for eradication of breast cancer using vinorelbine stealthy liposomes plus parthenolide stealthy liposomes.JOURNAL OF CONTROLLED RELEASE,129(1),18-25.
MLA Liu, Yang,et al."A potential target associated with both cancer and cancer stem cells: A combination therapy for eradication of breast cancer using vinorelbine stealthy liposomes plus parthenolide stealthy liposomes".JOURNAL OF CONTROLLED RELEASE 129.1(2008):18-25.
条目包含的文件
条目无相关文件。
个性服务
推荐该条目
保存到收藏夹
查看访问统计
导出为Endnote文件
谷歌学术
谷歌学术中相似的文章
[Liu, Yang]的文章
[Lu, Wan-Liang]的文章
[Guo, Jia]的文章
百度学术
百度学术中相似的文章
[Liu, Yang]的文章
[Lu, Wan-Liang]的文章
[Guo, Jia]的文章
必应学术
必应学术中相似的文章
[Liu, Yang]的文章
[Lu, Wan-Liang]的文章
[Guo, Jia]的文章
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。